Literature DB >> 17204554

Midkine is an autocrine activator of signal transducer and activator of transcription 3 in 3T3-L1 cells.

Erin R Cernkovich1, Jianbei Deng, Kunjie Hua, Joyce B Harp.   

Abstract

Mitotic clonal expansion is believed to be necessary for 3T3-L1 adipocyte formation. Signal transducer and activator of transcription 3 (STAT3), a mitogenic signaling protein, is activated through tyrosine phosphorylation during the proliferative phases of adipogenesis. We hypothesize that this signaling protein plays a key role in mitotic clonal expansion and differentiation. Here we determined that the adipocyte differentiation cocktail containing isobutylmethylxanthine, dexamethasone, and insulin (MDI) induced STAT3 tyrosine phosphorylation indirectly through the synthesis of an autocrine/paracrine factor. We further determined that the factor has heparin binding properties and identified the factor as midkine, a pleiotrophic growth factor previously associated with neuronal development and oncogenesis. Recombinant midkine induced STAT3 tyrosine phosphorylation in a time- and dose-dependent manner and stimulated the proliferation of postconfluent 3T3-L1 cells. Midkine neutralizing antibodies inhibited differentiation-induced STAT3 tyrosine phosphorylation as well as adipogenesis. These results show that MDI-induced synthesis and release of midkine explains the delayed activation of STAT3 during adipogenesis and that the midkine-STAT3 signaling pathway plays a necessary role in mitotic clonal expansion and differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17204554     DOI: 10.1210/en.2006-1106

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

Review 1.  Structure and function of midkine as the basis of its pharmacological effects.

Authors:  T Muramatsu
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 2.  Emerging roles of JAK-STAT signaling pathways in adipocytes.

Authors:  Allison J Richard; Jacqueline M Stephens
Journal:  Trends Endocrinol Metab       Date:  2011-05-10       Impact factor: 12.015

Review 3.  JAK-STAT in lipid metabolism of adipocytes.

Authors:  Dong Xu; Chunyan Yin; Sisi Wang; Yanfeng Xiao
Journal:  JAKSTAT       Date:  2013-12-06

Review 4.  The role of JAK-STAT signaling in adipose tissue function.

Authors:  Allison J Richard; Jacqueline M Stephens
Journal:  Biochim Biophys Acta       Date:  2013-06-02

5.  CXCL3 positively regulates adipogenic differentiation.

Authors:  Joji Kusuyama; Anna Komorizono; Kenjiro Bandow; Tomokazu Ohnishi; Tetsuya Matsuguchi
Journal:  J Lipid Res       Date:  2016-08-10       Impact factor: 5.922

Review 6.  Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases.

Authors:  Takashi Muramatsu
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

Review 7.  Midkine: a promising molecule for drug development to treat diseases of the central nervous system.

Authors:  Takashi Muramatsu
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

8.  Deletion of Trpm7 disrupts embryonic development and thymopoiesis without altering Mg2+ homeostasis.

Authors:  Jie Jin; Bimal N Desai; Betsy Navarro; Adriana Donovan; Nancy C Andrews; David E Clapham
Journal:  Science       Date:  2008-10-31       Impact factor: 47.728

9.  Control of adipogenic commitment by a STAT3-VSTM2A axis.

Authors:  Manal Al Dow; Maruhen Amir Datsch Silveira; Audrée Poliquin; Laura Tribouillard; Éric Fournier; Eva Trébaol; Blandine Secco; Romain Villot; Félix Tremblay; Steve Bilodeau; Mathieu Laplante
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-11-16       Impact factor: 4.310

10.  Midkine, a potential link between obesity and insulin resistance.

Authors:  Nengguang Fan; Haiyan Sun; Yifei Wang; Lijuan Zhang; Zhenhua Xia; Liang Peng; Yanqiang Hou; Weiqin Shen; Rui Liu; Yongde Peng
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.